Biomaterials Market
Biomaterials Market Forecasts to 2032 – Global Analysis By Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials and Other Types), Application and By Geography
According to Stratistics MRC, the Global Biomaterials Market is accounted for $49.40 billion in 2025 and is expected to reach $92.06 billion by 2032 growing at a CAGR of 9.3% during the forecast period. Biomaterials are natural or synthetic substances designed to interact with biological systems for medical or therapeutic purposes. They can be metals, ceramics, polymers, or composites, carefully engineered to restore, replace, or enhance the function of tissues and organs. Used in applications such as implants, prosthetics, drug delivery systems, and tissue engineering, biomaterials must exhibit biocompatibility, durability, and functionality without causing adverse immune responses. Their design often integrates biology, chemistry, materials science, and engineering to meet specific clinical needs. By bridging technology and biology, biomaterials play a crucial role in advancing modern healthcare, regenerative medicine, and biomedical innovation.
Market Dynamics:
Driver:
Rising prevalence of chronic and cardiovascular diseases
Rising global life expectancy and lifestyle-induced health issues continue to elevate demand for advanced biomaterials. Regenerative therapies and surgical applications benefit significantly from these materials’ compatibility and performance. Minimally invasive procedures further drive utilization across clinical settings. Expanding healthcare needs are reinforcing the strategic importance of biomaterials. Long-term market growth is being shaped by these evolving medical requirements.
Restraint:
Stringent regulatory and clinical approval processes
Medical-grade materials must meet rigorous safety and performance standards. Approval cycles are lengthy and vary across jurisdictions, increasing compliance costs. These challenges slow down innovation and delay commercialization. Smaller firms may find it difficult to navigate these requirements. Regulatory fragmentation continues to restrict rapid market expansion.
Opportunity:
Growing adoption of implantable medical devices
Integration with human tissue demands biomaterials that exhibit high biocompatibility and structural reliability. Applications span orthopedic implants, cardiovascular stents, dental restorations, and neuroprosthetic interfaces. Continuous advancements in material engineering are enhancing durability, functionality, and patient outcomes. Preference for minimally invasive and long-lasting medical solutions is rising across global healthcare systems. Adoption trends are accelerating innovation cycles within the biomaterials sector.
Threat:
High R&D and production costs
Developing safe and effective materials requires substantial investment in research, testing, and regulatory compliance. Production processes are often specialized and capital-intensive. Smaller players may struggle to compete with established firms. These cost pressures slow product development and market penetration. Economic barriers remain a persistent threat to growth.
Covid-19 Impact:
The Covid-19 pandemic had a mixed impact on the biomaterials market. Initially, disruptions in supply chains, manufacturing slowdowns, and reduced elective medical procedures hindered demand. Hospitals prioritized emergency care, delaying surgeries involving implants and prosthetics. However, the pandemic also accelerated the use of biomaterials in medical devices, diagnostics, and personal protective equipment. Increased investments in healthcare infrastructure and research further supported market recovery. Post-pandemic, rising focus on advanced healthcare solutions and regenerative medicine boosted demand for biomaterials.
The polymeric biomaterials segment is expected to be the largest during the forecast period
The polymeric biomaterials segment is expected to account for the largest market share during the forecast period due to their adaptability and broad clinical utility. These materials are widely used in cardiovascular, orthopedic, and wound care applications. Their flexibility, biocompatibility, and ease of customization make them ideal for diverse medical needs. Innovations in biodegradable and drug-releasing polymers are expanding their scope. They also support minimally invasive treatment approaches. This segment will continue to lead in both volume and innovation.
The ophthalmology segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the ophthalmology segment is predicted to witness the highest growth rate increasing demand for precision eye care solutions. Biomaterials are being used in intraocular lenses, corneal scaffolds, and ocular drug delivery systems. Aging populations and rising cases of vision impairment are fuelling adoption. Transparent and biocompatible materials are improving surgical outcomes. Minimally invasive ophthalmic procedures are gaining traction globally. This segment is poised for rapid expansion in the coming years.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share by high adoption of innovative medical technologies, and strong research and development activities. The region shows widespread use of biomaterials in orthopedics, cardiovascular devices, wound healing, and cosmetic surgery. Strategic collaborations between universities, research institutions, and biotech firms foster innovation and product development. Established industry players, favorable regulatory policies, and the rising preference for minimally invasive treatments collectively fuel market expansion. Growing awareness about personalized healthcare and regenerative medicine also strengthens the market landscape.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rapid urbanization, an expanding healthcare infrastructure, and growing investments in advanced medical technologies. Increasing prevalence of chronic diseases and rising demand for orthopedic, cardiovascular, and dental implants further support market growth. Countries such as China, India, and Japan play a significant role due to large patient populations and improving healthcare access. Additionally, government initiatives promoting research and local production of biomaterials encourage innovation, making the region a hotspot for future market expansion and development.

Key players in the market
Some of the key players in Biomaterials Market include BASF SE, Evonik Industries AG, Corbion N.V., Covestro AG, Celanese Corporation, Carpenter Technology Corporation, Victrex plc, Zimmer Biomet, Johnson & Johnson, Medtronic plc, Stryker Corporation, DSM-Firmenich, Noble Biomaterials Inc., CoorsTek Inc. and CeramTec GmbH.
Key Developments:
In July 2025, BASF signed a global framework agreement with CATL to supply advanced cathode active materials for lithium-ion batteries. While focused on energy storage, the partnership leverages BASF’s biomaterials expertise in sustainable sourcing and circular chemistry to support CATL’s green transformation goals.
In January 2025, Evonik formed a joint venture with Fuhua Tongda Chemical Co., Ltd. in Sichuan, China, to produce specialty hydrogen peroxide for medical and semiconductor applications. The venture builds on a prior licensing agreement and supports Evonik’s biomaterials strategy by securing sustainable raw materials for high-purity processing.
Types Covered:
• Metallic Biomaterials
• Polymeric Biomaterials
• Ceramic Biomaterials
• Natural Biomaterials
• Other Types
Applications Covered:
• Cardiovascular
• Orthopedic
• Ophthalmology
• Dental
• Wound Healing
• Wound Healing
• Neurology
• Other Applications
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Biomaterials Market, By Type
5.1 Introduction
5.2 Metallic Biomaterials
5.2.1 Stainless Steel
5.2.2 Titanium & Titanium Alloys
5.2.3 Cobalt-Chromium Alloys
5.3 Polymeric Biomaterials
5.3.1 Polymethyl Methacrylate (PMMA)
5.3.2 Polyethylene (PE)
5.3.3 Polypropylene (PP)
5.3.4 Polyvinyl Chloride (PVC)
5.3.5 Silicone
5.4 Ceramic Biomaterials
5.4.1 Alumina
5.4.2 Zirconia
5.4.3 Calcium Phosphates
5.5 Natural Biomaterials
5.5.1 Collagen
5.5.2 Gelatin
5.5.3 Chitosan
5.5.4 Alginate
5.5.5 Silk
5.5.6 Hyaluronic Acid
5.6 Other Types
6 Global Biomaterials Market, By Application
6.1 Introduction
6.2 Cardiovascular
6.2.1 Stents & Grafts
6.2.2 Heart Valves
6.2.3 Pacemakers & Implantable Devices
6.3 Orthopedic
6.3.1 Joint Replacement
6.3.2 Bone Plates & Screws
6.3.3 Spinal Implants
6.4 Ophthalmology
6.4.1 Contact Lenses
6.4.2 Intraocular Lenses
6.4.3 Corneal Implants
6.5 Dental
6.5.1 Dental Implants
6.5.2 Crowns & Bridges
6.5.3 Dentures
6.6 Wound Healing
6.6.1 Surgical Sutures
6.6.2 Tissue Sealants & Adhesives
6.6.3 Dressings
6.7 Neurology
6.7.1 Neural Implants
6.7.2 Shunts
6.7.3 Electrodes
6.8 Other Applications
7 Global Biomaterials Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 BASF SE
9.2 Evonik Industries AG
9.3 Corbion N.V.
9.4 Covestro AG
9.5 Celanese Corporation
9.6 Carpenter Technology Corporation
9.7 Victrex plc
9.8 Zimmer Biomet
9.9 Johnson & Johnson
9.10 Medtronic plc
9.11 Stryker Corporation
9.12 DSM-Firmenich
9.13 Noble Biomaterials Inc.
9.14 CoorsTek Inc.
9.15 CeramTec GmbH
List of Tables
1 Global Biomaterials Market Outlook, By Region (2024-2032) ($MN)
2 Global Biomaterials Market Outlook, By Type (2024-2032) ($MN)
3 Global Biomaterials Market Outlook, By Metallic Biomaterials (2024-2032) ($MN)
4 Global Biomaterials Market Outlook, By Stainless Steel (2024-2032) ($MN)
5 Global Biomaterials Market Outlook, By Titanium & Titanium Alloys (2024-2032) ($MN)
6 Global Biomaterials Market Outlook, By Cobalt-Chromium Alloys (2024-2032) ($MN)
7 Global Biomaterials Market Outlook, By Polymeric Biomaterials (2024-2032) ($MN)
8 Global Biomaterials Market Outlook, By Polymethyl Methacrylate (PMMA) (2024-2032) ($MN)
9 Global Biomaterials Market Outlook, By Polyethylene (PE) (2024-2032) ($MN)
10 Global Biomaterials Market Outlook, By Polypropylene (PP) (2024-2032) ($MN)
11 Global Biomaterials Market Outlook, By Polyvinyl Chloride (PVC) (2024-2032) ($MN)
12 Global Biomaterials Market Outlook, By Silicone (2024-2032) ($MN)
13 Global Biomaterials Market Outlook, By Ceramic Biomaterials (2024-2032) ($MN)
14 Global Biomaterials Market Outlook, By Alumina (2024-2032) ($MN)
15 Global Biomaterials Market Outlook, By Zirconia (2024-2032) ($MN)
16 Global Biomaterials Market Outlook, By Calcium Phosphates (2024-2032) ($MN)
17 Global Biomaterials Market Outlook, By Natural Biomaterials (2024-2032) ($MN)
18 Global Biomaterials Market Outlook, By Collagen (2024-2032) ($MN)
19 Global Biomaterials Market Outlook, By Gelatin (2024-2032) ($MN)
20 Global Biomaterials Market Outlook, By Chitosan (2024-2032) ($MN)
21 Global Biomaterials Market Outlook, By Alginate (2024-2032) ($MN)
22 Global Biomaterials Market Outlook, By Silk (2024-2032) ($MN)
23 Global Biomaterials Market Outlook, By Hyaluronic Acid (2024-2032) ($MN)
24 Global Biomaterials Market Outlook, By Other Types (2024-2032) ($MN)
25 Global Biomaterials Market Outlook, By Application (2024-2032) ($MN)
26 Global Biomaterials Market Outlook, By Cardiovascular (2024-2032) ($MN)
27 Global Biomaterials Market Outlook, By Stents & Grafts (2024-2032) ($MN)
28 Global Biomaterials Market Outlook, By Heart Valves (2024-2032) ($MN)
29 Global Biomaterials Market Outlook, By Pacemakers & Implantable Devices (2024-2032) ($MN)
30 Global Biomaterials Market Outlook, By Orthopedic (2024-2032) ($MN)
31 Global Biomaterials Market Outlook, By Joint Replacement (2024-2032) ($MN)
32 Global Biomaterials Market Outlook, By Bone Plates & Screws (2024-2032) ($MN)
33 Global Biomaterials Market Outlook, By Spinal Implants (2024-2032) ($MN)
34 Global Biomaterials Market Outlook, By Ophthalmology (2024-2032) ($MN)
35 Global Biomaterials Market Outlook, By Contact Lenses (2024-2032) ($MN)
36 Global Biomaterials Market Outlook, By Intraocular Lenses (2024-2032) ($MN)
37 Global Biomaterials Market Outlook, By Corneal Implants (2024-2032) ($MN)
38 Global Biomaterials Market Outlook, By Dental (2024-2032) ($MN)
39 Global Biomaterials Market Outlook, By Dental Implants (2024-2032) ($MN)
40 Global Biomaterials Market Outlook, By Crowns & Bridges (2024-2032) ($MN)
41 Global Biomaterials Market Outlook, By Dentures (2024-2032) ($MN)
42 Global Biomaterials Market Outlook, By Wound Healing (2024-2032) ($MN)
43 Global Biomaterials Market Outlook, By Surgical Sutures (2024-2032) ($MN)
44 Global Biomaterials Market Outlook, By Tissue Sealants & Adhesives (2024-2032) ($MN)
45 Global Biomaterials Market Outlook, By Dressings (2024-2032) ($MN)
46 Global Biomaterials Market Outlook, By Neurology (2024-2032) ($MN)
47 Global Biomaterials Market Outlook, By Neural Implants (2024-2032) ($MN)
48 Global Biomaterials Market Outlook, By Shunts (2024-2032) ($MN)
49 Global Biomaterials Market Outlook, By Electrodes (2024-2032) ($MN)
50 Global Biomaterials Market Outlook, By Other Applications (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY

We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.